Skip to main content

UK's AstraZeneca Buying US Biotech Firm Alexion For $39 Billion

British pharmaceuticals group AstraZeneca, which is finalising a vaccine against Covid-19, said Saturday it was buying US biotech firm Alexion for $39 billion to boost its work on immunology.

https://ift.tt/eA8V8J

Comments

Popular posts from this blog